Navigation Links
The EntreTech Forum Presents... Greening Of America - The Conversion of Bio-Agriculture, Bio-Energy, and Bio-Products to Eco-Sustainable Businesses
Date:1/30/2009

BOSTON, Jan. 30 /PRNewswire/ -- At The EntreTech Forum's February 17th meeting, the panel of business, technology and investment professionals - all contributors, supporters and participants in the emerging bio-economy - will emphasize businesses and technologies that present eco-sustainable activities for this "Triple Bio" play of bio-agriculture, bio-energy, and bio-products.

Last summer we saw the impact of peaking global production of fossil hydrocarbons in the massive price increase for our fuels. Even more devastating was the impact to the agriculture sector for food production, processing and transportation.

A Bio-Economy is emerging with bio-agriculture, bio-energy, bio-products taking on new emphasis in our national quest for energy independence and sustainability.

As Chad Kruger of Washington State University identified, this "Triple Bio" involves three interwoven tracks of:

  • bio-agriculture to produce food and feedstock in an environmentally and energetically sustainable way. It is a suite of concepts, practices and technologies which capitalize on biological processes to maximize resource conservation and resource-use.

  • bio-products research and development to process raw biological feedstock into useful and higher value materials. This refers to refined, value-added materials derived from biomass, such as industrial, biological, medical and nutraceutical products.

  • bio-energy to reduce our reliance on fossil fuels for transportation fuels, electricity and heat. It refers to both power (electricity and heat) and liquid fuels derived from biomass. 

       Tuesday, February 17, 2
'/>"/>
SOURCE  The EntreTech Forum
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 

Related biology technology :

1. Novavax CMO to Present at Phacilitate Vaccine Forum Washington 2009
2. ImmunoVaccine Technologies Presents at OneMed Place Finance Forum
3. Victhom to Participate in the OneMedPlace Finance Forum
4. GeneNews to exhibit ColonSentry(TM) at Family Medicine Forum 2008
5. Cadient Groups GEL Interactive Technologies to Present and Exhibit at CBIs 5th Annual Forum
6. InNexus Biotechnology CEO to Present at the 7th Annual BIO Investor Forum
7. Novavax CEO to Present at BIO Investor Forum 2008
8. Peregrine Pharmaceuticals to Present at BIO Investor Forum 2008
9. Nile Therapeutics to Present at the 7th Annual BIO Investor Forum
10. Neurobiological Technologies to Present at the BIO Investor Forum in San Francisco on October 30, 2008
11. Gerson Lehrman Group and BIO Collaborate to Identify Scientific Expertise for the Seventh Annual BIO Investor Forum
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/27/2009)... , DURHAM, N.C., Nov. 27 ...ll initiate water-soluble carbon nanotube-based ca... water-soluble carbon nanotubes, which have functi...on with cancer drugs, was developed in partnership...njugated carbon nanotubes serves as a drug deliver...
(Date:11/25/2009)... , BOSTON, Nov. 25 Biotec... virus, genomic data from the 1918 pandemic throug...rrent H1N1 pandemic, today issued its latest bioch...hat the lethality of the H1N1 ("Swine Flu") virus ... the virus,s current outbreak in the spring of 200...
(Date:11/25/2009)... , NEW YORK, Nov. 25 Repo...report is available in its catalogue: ,, Brazi... ,, http://www.reportlinker.com/p0165503/Braz...3.html ,, Brazil Bioethanol Market Analysis an...rt provides detailed analysis and forecasts of the...
(Date:11/24/2009)... The New York investment bank K...X:NEU) has agreed an AU$6.7 mil convertible note p...r. The private placement was arranged by KTA Capit...or. , New York (PRWEB) No...ment bank KTA Capital, LLC ("KTA Capital"...
Breaking Biology Technology:North Carolina Based Cromoz Inc. Launches Carbon Nanotechnology for Target Drug Delivery System in Cancer Treatment in Hyderabad, India 2Biological H1N1 Vaccines: Too Little, Too Late 2Biological H1N1 Vaccines: Too Little, Too Late 3Biological H1N1 Vaccines: Too Little, Too Late 4Biological H1N1 Vaccines: Too Little, Too Late 5Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 2Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 3Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 4Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 5Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 6Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 7Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 8Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 9Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 10KTA Capital Arranges an AU$6.7 Million Private Placement by Neuren Pharmaceuticals 2
...oSciences LLC and Martek Biosciences Corporation t...y develop and commercialize a canola seed,that pro... acid)., Under the terms of the agreement, Martek...eed, which will produce a DHA-rich canola oil that...n" of food industry oils.,The intent of the collab...
...) today announced that it has provided a notice to...ght executive officers, that their,employment with...rce,reduction follows the announcement earlier thi...nt of its lead product, Specifid(TM), after it fai...l., The remaining employees will manage a plan to...
...aq: GPRO ) announced today that the Company has l...y specific molecular diagnostic test to detect,hig...which causes cervical,cancer. The APTIMA HPV Assay... sale in 13 European Union countries., "The CE ma... reflect,Gen-Probe,s commitment to the development...
Other Biology Technology:Dow AgroSciences, Martek Biosciences Form Alliance to Bring Omega-3 Fatty Acids to Food Industry 2Dow AgroSciences, Martek Biosciences Form Alliance to Bring Omega-3 Fatty Acids to Food Industry 3Favrille Announces Workforce Reduction 2Gen-Probe Launches in Europe CE-Marked APTIMA(R) HPV Assay for Detection of Human Papillomavirus 2Gen-Probe Launches in Europe CE-Marked APTIMA(R) HPV Assay for Detection of Human Papillomavirus 3Gen-Probe Launches in Europe CE-Marked APTIMA(R) HPV Assay for Detection of Human Papillomavirus 4Gen-Probe Launches in Europe CE-Marked APTIMA(R) HPV Assay for Detection of Human Papillomavirus 5
(Date:11/26/2009)...s Aureus ) and other drug-resistant bacteria could...type devices have been developed to offer safe, qu... Two prototype devices have been developed: one f...nds and feet) in hospitals and public spaces where... shoot bacteria-killing agents into infested chron...
(Date:11/25/2009)...cers and ambulance workers faced a terrifying resc...battled to save people from the collapsing Twin To...acuated as many people as they could in an area wh...ng their jobs even harder was the problem of poor ...ives jammed mobile networks with calls and the eme...
(Date:11/25/2009)...sors recently received funding from the National S...icial to understanding the environment. The three ...assistant professor in the Department of Biologica...rate research projects. , His first project, tit...Functions from the Leaf to the Landscape," will ex...
Breaking Biology News(10 mins):Plasma produces KO cocktail for MRSA 2Plasma produces KO cocktail for MRSA 3Magic box for mission impossible 2Magic box for mission impossible 3Kent State University professors focus research on the environment with grants totaling $890,000 2JAG Media Holdings Inc Announces Completion of Acquisition of CardioGenics Inc 53384 1JAG Media Holdings Inc Announces Completion of Acquisition of CardioGenics Inc 53384 2JAG Media Holdings Inc Announces Completion of Acquisition of CardioGenics Inc 53384 3JAG Media Holdings Inc Announces Completion of Acquisition of CardioGenics Inc 53384 4Duane Reade Holdings Inc Announces Pricing of Offering of 11 75 25 Senior Secured Notes Due 2015 53380 1Duane Reade Holdings Inc Announces Pricing of Offering of 11 75 25 Senior Secured Notes Due 2015 53380 2Duane Reade Holdings Inc Announces Pricing of Offering of 11 75 25 Senior Secured Notes Due 2015 53380 3INVEGA 28R 29 Approved as the First and Only Treatment for Schizoaffective Disorder 53377 1INVEGA 28R 29 Approved as the First and Only Treatment for Schizoaffective Disorder 53377 2INVEGA 28R 29 Approved as the First and Only Treatment for Schizoaffective Disorder 53377 3INVEGA 28R 29 Approved as the First and Only Treatment for Schizoaffective Disorder 53377 4INVEGA 28R 29 Approved as the First and Only Treatment for Schizoaffective Disorder 53377 5INVEGA 28R 29 Approved as the First and Only Treatment for Schizoaffective Disorder 53377 6INVEGA 28R 29 Approved as the First and Only Treatment for Schizoaffective Disorder 53377 7
..., Calif.) A new study by researchers at UC Davis ...d deaths of some epilepsy patients may be a result...he during seizures. , "Significant drops in blood...patients with partial seizures," said study senior...C Davis Medical Center and director of the UC Davi...
...- (Nov. 17, 2008) -- A "chip" or array that can qu...her diseases associated with chromosomal abnormali...s in a series of 300 cases at Baylor College of Me...in the current issue of the journal Prenatal Diag... Beaudet and Dr. Sau Wai Cheung at BCM, described ...
...family history of prostate cancer and African-Amer...se, with a twofold to sevenfold increased risk. As...lt. , "There have been years of effort to try to ...th prostate cancer as there are for breast cancer,...e Cancer Risk Assessment Program (PRAP) at Fox Cha...
Other Biology News:Drops in blood oxygen levels may be key to sudden death in some epilepsy patients 2Drops in blood oxygen levels may be key to sudden death in some epilepsy patients 3Microarray analysis improves prenatal diagnosis 2Microarray analysis improves prenatal diagnosis 3Genetic risk factors may tailor prostate cancer screening approaches 2
Rabbit Anti-Human DAP-1 Monoclonal Antibody, Unconjugated from Upstate
Mouse Anti-Angiotensin II Type 1 Receptor Monoclonal Antibody, Unconjugated, Clone TONI-1 from Abcam
1/4" to 1/8" Adapter for Reflectance Probe Holder from Ocean Optics
...amide (GLP-1), C-terminal reactive. Cross-reacts f...reactivity with the unamidated forms GLP-1(7-37) a...GLP-2, glucagon, hGIP and VIP.,SPECIES REACTIVIT... all mammalian species studied except guinea pig a...
Biology Products: